Archive: 06/02/2015

Lurasidone in schizophrenia: Added benefit is not proven

The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment ...

Ebola nightmare does not end with recovery: WHO

People who survive Ebola continue to suffer from serious physical and psychological ailments and require care long after the deadly virus has left their bodies, the World Health Organization said Friday.

page 2 from 6